CI Investments Inc
ICPT

CI Investments Inc’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

CI Investments Inc’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-123,736
Closed -$2.01M – 1457
2022
Q1 		$2.01M Buy
+123,736
New +$1.94M 0.01% 379

Other funds holding ICPT

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

CI Investments Inc's ICPT Position: Q2 2022 in Review

CI Investments Inc sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q2 2022, closing a stake of 123,736 shares — an estimated $2.01M sold.

CI Investments Inc first reported a position in ICPT in Q1 2022 and held it in 1 quarter. The position peaked at $2.01M in Q1 2022. 144 funds tracked by Wall St. Rank hold ICPT as of Q2 2022.

  • CI Investments Inc reported no remaining Intercept Pharmaceuticals, Inc. position as of Q2 2022 after selling out during the quarter.
  • CI Investments Inc sold 123,736 Intercept Pharmaceuticals, Inc. shares in Q2 2022, an estimated $2.01M.
  • CI Investments Inc first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2022 and held it in 1 quarter.
  • CI Investments Inc's Intercept Pharmaceuticals, Inc. position peaked at $2.01M in Q1 2022.
  • 144 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q2 2022.

Based on CI Investments Inc's 13F filing for Q2 2022, filed 12 Aug 2022.